Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_assertion type Assertion NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_head.
- NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_assertion description "[By immunohistochemistry, we determined that the ESM-1 immunoreactivity was significantly correlated with the tumor size, depth of invasion, nodal status, distant metastasis and Dukes' stage, and was an independent prognostic factor for disease recurrence and worse survival outcome (P=0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_provenance.
- NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_assertion evidence source_evidence_literature NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_provenance.
- NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_assertion SIO_000772 22948784 NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_provenance.
- NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_assertion wasDerivedFrom befree-20140225 NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_provenance.
- NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_assertion wasGeneratedBy ECO_0000203 NP465832.RAp25NGhDUAvq_QixSLHQ1ELsl34Bt7nn1gWUKGcQjENo130_provenance.